Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
Lin, Xi, Antalffy, Barbara, Kang, Dongcheul, Orr, Harry T., Zoghbi, Huda Y.·2000·Nature Neuroscience
DOI 10.1038/72101
Cited by (374)
Items 201–300 of 374
- Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in DrosophilaLeeanne McGurk, Nancy M. Bonini · 2011 · Human Molecular Genetics
- Nuclear localization of N‐terminal mutant huntingtin is cell cycle dependentEster Martı́n-Aparicio, Jesús Ávila, José J. Lucas · 2002 · European Journal of Neuroscience
- Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies.Judit M. Perez Ortiz, H. Orr · 2018 · Advances in Experimental Medicine and Biology
- Brainstem and striatal volume changes are detectable in under 1 year and predict motor decline in spinocerebellar ataxia type 1T. Koscik, Lauren M. Sloat, E. van der Plas, J. Joers, D. Deelchand, C. Lenglet, G. Öz, P. Nopoulos · 2020 · Brain Communications
- Positioning the genome within the nucleusPernette J. Verschure · 2004 · Biology of the Cell
- Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxiaSherry-Ann N. Brown, Leslie M. Loew · 2012 · BMC Systems Biology
- Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1Ravi Chopra, David D. Bushart, John-Paul R. Cooper, Dhananjay Yellajoshyula, Logan M. Morrison, Hao-Ran Huang, Hillary P. Handler, Lu-Ke J. Man, Warunee Dansithong, D. Scoles et al. · 2020 · bioRxiv
- Suppression of Calbindin-D28k Expression Exacerbates SCA1 Phenotype in a Disease Mouse ModelParminder J. S. Vig, Jinrong Wei, Qingmei Shao, Maripar E. Lopez, Rebecca F. Halperin, Jill D. Gerber · 2011 · The Cerebellum
- Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicityMorwena Latouche, Pascal Fragner, Elodie Martin, Khalid Hamid El Hachimi, Cecilia Soussi Zander, Annie Sittler, Merle Ruberg, Alexis Brice, Giovanni Stévanin · 2005 · Molecular and Cellular Neuroscience
- Therapeutic gene silencing strategies for polyglutamine disordersJanine Scholefield, Matthew J. A. Wood · 2009 · Trends in Genetics
- Amino Acids in a Region of Ataxin-1 Outside of the Polyglutamine Tract Influence the Course of Disease in SCA1 Transgenic MicePamela J. Skinner, Cynthia Vierra‐Green, Effat S. Emamian, Huda Yahya Zoghbi, Harry T. Orr · 2002 · NeuroMolecular Medicine
- Protein Aggregation and Polyasparagine-Mediated Cellular Toxicity inSaccharomyces cerevisiaeTheodore W. Peters, Mingxia Huang · 2007 · Prion
- Region‐specific preservation of Purkinje cell morphology and motor behavior in the ATXN1[82Q] mouse model of spinocerebellar ataxia 1Joshua J. White, Laurens W. J. Bosman, François G. C. Blot, Catarina Osório, Bram W. Kuppens, Wilhelmina H. J. J. Krijnen, Charlotte A. Andriessen, Chris I. De Zeeuw, Dick Jaarsma, Martijn Schonewille · 2021 · Brain Pathology
- Kaleidoscopic protein–protein interactions in the life and death of ataxin-1: new strategies against protein aggregationCesira de Chiara, Annalisa Pastore · 2014 · Trends in Neurosciences
- LANP mediates neuritic pathology in Spinocerebellar ataxia type 1M. Cvetanovic, Rupinder Kular, Puneet Opal · 2012 · Neurobiology of Disease
- Posterior cerebellar Purkinje cells in an SCA5/SPARCA1 mouse model are especially vulnerable to the synergistic effect of loss of β-III spectrin and GLASTEmma Perkins, Daumante Šuminaite, Yvonne L. Clarkson, Sin Kwan Lee, Alastair Robert Lyndon, Jeffrey D. Rothstein, David J. A. Wyllie, Kohichi Tanaka, M. T. Jackson · 2016 · Human Molecular Genetics
- Pharmacological enhancement of retinoid-related orphan receptor α function mitigates spinocerebellar ataxia type 3 pathology.Masashi Watanave, Chiaki Hoshino, A. Konno, Y. Fukuzaki, Y. Matsuzaki, T. Ishitani, H. Hirai · 2019 · Neurobiology of Disease
- The Ins and Outs of a Polyglutamine Neurodegenerative Disease: Spinocerebellar Ataxia Type 1 (SCA1)Harry T. Orr · 2000 · Neurobiology of Disease
- Prenylcysteine carboxylmethyltransferase is essential for the earliest stages of liver development in miceXi Lin, Joonil Jung, Dongcheul Kang, Bisong Xu, Kenneth S. Zaret, Huda Yahya Zoghbi · 2002 · Gastroenterology
- Polyglutamine-mediated aggregation and cell death.T. de Cristofaro, A. Affaitati, A. Feliciello, E. Avvedimento, S. Varrone · 2000 · Biochemical and Biophysical Research Communications - BBRC
- Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencingMarie Coutelier, Giovanni Stévanin, Alexis Brice · 2015 · Journal of Neurology
- Mutant Ataxin-1 Inhibits Neural Progenitor Cell Proliferation in SCA1Marija Cvetanović, Yuan-Shih Hu, Puneet Opal · 2016 · The Cerebellum
- Purkinje Neurons with Loss of STIM1 Exhibit Age-Dependent Changes in Gene Expression and Synaptic ComponentsSreeja Kumari Dhanya, Gaiti Hasan · 2021 · Journal of Neuroscience
- Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegenerationBryce Nelson, S Nishimura, Hirotaka Kanuka, Erina Kuranaga, Masato Inoue, Gen Hori, Hiroyuki Nakahara, Masayuki Miura · 2005 · Cell Death and Differentiation
- Mouse Models of Triplet Repeat DiseasesGillian P. Bates, Roman Gonitel · 2006 · Molecular Biotechnology
- Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseasesBernd Friedrich, Philipp Euler, Ruhtraut Ziegler, Alexandre Kuhn, G. Bernhard Landwehrmeyer, Ruth Luthi‐Carter, Cornelius Weiller, Sabine Hellwig, Birgit Zucker · 2012 · Brain Research
- Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 miceEllie M. Carrell, Megan S. Keiser, Ashley B. Robbins, Beverly L. Davidson · 2022 · Molecular Therapy — Methods & Clinical Development
- Roles of Double-strand Breaks, Nicks, and Gaps in Stimulating Deletions of CTG·CAG Repeats by Intramolecular DNA RepairMicheal L. Hebert, Robert D. Wells · 2005 · Journal of Molecular Biology
- Direct Activation of TRPC3 Channels by the Antimalarial Agent ArtemisininNicole D. Urban, Michael Schaefer · 2020 · Cells
- Polyglutamine Disorders Including Huntington's DiseaseSokol V. Todi, Aislinn Joanmarie Williams, Henry Lauris Paulson · 2007 · Elsevier eBooks
- Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?J. Paul Taylor, Kenneth H. Fischbeck · 2002 · Trends in Molecular Medicine
- Spinocerebellar ataxias caused by polyglutamine expansions.G. Stevanin, A. Dürr, A. Brice · 2002 · Advances in Experimental Medicine and Biology
- New light on polyglutamine neurodegenerative disorders: interference with transcriptionChristian Néri · 2001 · Trends in Molecular Medicine
- Identification of a novel phosphorylation site in ataxin-1Cynthia Vierra‐Green, Harry T. Orr, Huda Yahya Zoghbi, Deborah A. Ferrington · 2004 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- A Novel Central Nervous System–Enriched Spinocerebellar Ataxia Type 7 Gene ProductDavid D. Einum, Anna M. Clark, Jeannette J. Townsend, Louis J. Ptáček, Ying‐Hui Fu · 2003 · Archives of Neurology
- Excitatory Amino Acid Transporters as Therapeutic Targets in the Treatment of Neurological Disorders: Their Roles and Therapeutic ProspectsGuirui Zhang, Shupeng Huang, Mingzhen Wei, Yongmo Wu, Jinhui Wang · 2025 · Neurochemical Research
- Protein-Protein Interactions as a Strategy towards Protein-Specific Drug Design: The Example of Ataxin-1C. de Chiara, R. Menon, G. Kelly, A. Pastore · 2013 · PLoS ONE
- Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1Yusuke Hatanaka, K. Watase, K. Wada, Y. Nagai · 2015 · Scientific Reports
- Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1Kyota Fujita, Ying Mao, Shigenori Uchida, Xi-Gu Chen, Hiroki Shiwaku, T. Tamura, Hikaru Ito, K. Watase, Hidenori Homma, K. Tagawa et al. · 2017 · Nature Communications
- Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathyKarine Mérienne, James S. Friedman, Masayuki Akimoto, Gretta Abou Sleymane, Chantal Weber, Anand Swaroop, Yvon Trottier · 2007 · Neurobiology of Disease
- Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expressionMatthew T. Lorincz, Peter J. Detloff, Roger L. Albin, K. Sue O’Shea · 2004 · Molecular and Cellular Neuroscience
- Molecular pathogenesis of spinal and bulbar muscular atrophyDiane E. Merry · 2001 · Brain Research Bulletin
- Therapeutic Strategies for Spinocerebellar Ataxia Type 1Laurie M.C. Kerkhof, Bart P.C. van de Warrenburg, Willeke van Roon‐Mom, Ronald A.M. Buijsen · 2023 · Biomolecules
- Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxiaSherry-Ann N. Brown, Leslie M. Loew · 2015 · Frontiers in Neuroscience
- Motor and Cerebellar Architectural Abnormalities during the Early Progression of Ataxia in a Mouse Model of SCA1 and How Early Prevention Leads to a Better Outcome Later in LifeMohamed F. Ibrahim, Emmet M. Power, Kay Potapov, Ruth M. Empson · 2017 · Frontiers in Cellular Neuroscience
- Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1Kimberly Luttik, Leon Tejwani, Hyoungseok Ju, T. Driessen, C. Smeets, Chandrakanth Reddy Edamakanti, Aryaan Khan, Joy Yun, Puneet Opal, Janghoo Lim · 2022 · Proceedings of the National Academy of Sciences of the United States of America
- Huntington's diseaseRaphael M. Bonelli, M. Flint Beal · 2012 · Handbook of clinical neurology
- Long-term oral administration of the NMDA receptor antagonist memantine extends life span in spinocerebellar ataxia type 1 knock-in miceAkira Iizuka, Kazuhiro Nakamura, Hirokazu Hirai · 2015 · Neuroscience Letters
- The ubiquitin-conjugating enzyme UbcH6 regulates the transcriptional repression activity of the SCA1 gene product ataxin-1.Soyeon Lee, Sung-Hoi Hong, Seongman Kang · 2008 · Biochemical and Biophysical Research Communications - BBRC
- Gain-of-function screen identifies a role of the Sec61α translocon in Drosophila postmitotic neurotoxicityHirotaka Kanuka, Tetsuo Hiratou, Tatsushi Igaki, Hiroshi Kanda, Erina Kuranaga, Kazunobu Sawamoto, Toshiro Aigaki, Hideyuki Okano, Masayuki Miura · 2005 · Biochimica et Biophysica Acta (BBA) - General Subjects
- Gene, Stem Cell, and Alternative Therapies for SCA 1Jacob L. Wagner, Deirdre M. A. O’Connor, Anthony Donsante, Nicholas M. Boulis · 2016 · Frontiers in Molecular Neuroscience
- Diseases of movement and system degenerationsPaul G. Ince, Brent Clark, Janice L. Holton, Tamás Révész, Stephen B. Wharton · 2008 · CRC Press eBooks
- Localization of ataxin-2 within the cerebellar cortex of the ratFrancesca Romana Fusco, Maria Teresa Viscomi, Giorgio Bernardi, Marco Molinari · 2001 · Brain Research Bulletin
- Functional contributions of glutamate transporters at the parallel fibre to Purkinje neuron synapse–relevance for the progression of cerebellar ataxiaEmmet M. Power, Ruth M. Empson · 2014 · Cerebellum & Ataxias
- Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitinMaria Tsirigotis, Mingxiang Tang, M. Beyers, M. Zhang, John Woulfe, Douglas A. Gray · 2005 · Neuropathology and Applied Neurobiology
- Hprt (CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridineSara J. Tallaksen‐Greene, Jared M. Ordway, Andrew B. Crouse, Walker S. Jackson, Peter J. Detloff, Roger L. Albin · 2003 · The Journal of Comparative Neurology
- Radiological hints for differentiation of cerebellar multiple system atrophy from spinocerebellar ataxiaHung-Chieh Chen, Li‐Hua Lee, Jiing‐Feng Lirng, Bing‐Wen Soong · 2022 · Scientific Reports
- The Emerging Key Role of the mGluR1-PKCγ Signaling Pathway in the Pathogenesis of Spinocerebellar Ataxias: A Neurodevelopmental ViewpointQin‐Wei Wu, Josef P. Kapfhammer · 2022 · International Journal of Molecular Sciences
- Overview of autosomal dominant ataxiasS. H. Subramony · 2011 · Handbook of clinical neurology
- Role of tissue transglutaminase type 2 in calbindin–D28k interaction with ataxin-1Parminder J. S. Vig, J. Wei, Qingmei Shao, Michael D. Hebert, Sub H. Subramony, Lamari Sutton · 2007 · Neuroscience Letters
- Impact of Reduced Cerebellar EAAT Expression on Purkinje Cell Firing Pattern of NPC1-deficient MiceMichael Rabenstein, Franziska Peter, Arndt Rolfs, Moritz J. Frech · 2018 · Scientific Reports
- Polyglutamine spinocerebellar ataxias: emerging therapeutic targetsAndreia Neves‐Carvalho, Sara Duarte‐Silva, Andreia Teixeira‐Castro, Patrı́cia Maciel · 2020 · Expert Opinion on Therapeutic Targets
- Dentatorubral-pallidoluysian atrophy (DRPLA)Shoji Tsuji · 2000 · Springer eBooks
- Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1Catarina Osório, Joshua J. White, Heiling Lu, Gerrit Cornelis Beekhof, Francesca Romana Fiocchi, Charlotte A. Andriessen, Stéphanie Dijkhuizen, Laura C. Post, Martijn Schonewille · 2022 · Brain
- Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse CortexKimberly P. Luttik, Víctor Olmos, Ashley Owens, A. Khan, Joy Yun, Terri M. Driessen, Janghoo Lim · 2022 · Cells
- Spinobulbar muscular atrophy (Kennedy's disease)Jean‐Marc Gallo · 2004 · Handbook of clinical neurophysiology
- Spinocerebellar Ataxia Type 10: A Disease Caused by a Large ATTCT Repeat ExpansionTohru Matsuura, Tetsuo Ashizawa · 2002 · Advances in experimental medicine and biology
- Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal deathMari Suzuki, Tatsuro Koike · 2005 · Journal of Neuroscience Research
- Jan Evangelista Purkyně and the Cerebellum Then and NowF Vožeh · 2015 · Physiological Research
- Homeostasis of glutamate neurotransmission is altered in Drosophila Inositol 1,4,5-trisphosphate receptor mutantsS. Nair, Neha Agrawal, G. Hasan · 2007 · Invertebrate Neuroscience
- Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxiasClévio Nóbrega, Adriana Marcelo, Ana Teresa Rajado, André Conceição, Bernardo Estevam, Carlos A. Matos, David V.C. Brito, Inês T. Afonso, José Miguel Codêsso, Rebekah Koppenol et al. · 2025 · Cell Death and Disease
- Dynamics of calcium and its roles in the dendrite of the cerebellar Purkinje cellTakafumi Inoue · 2003 · The Keio Journal of Medicine
- Autosomal Dominant Spinocerebellar Ataxias and Episodic AtaxiasFranco Taroni, Luisa Chiapparini, Caterina Mariotti · 2012 · Springer eBooks
- Functional Complementation of Drosophila itpr Mutants by Rat Itpr1Sumita Chakraborty, Gaiti Hasan · 2012 · Journal of Neurogenetics
- Olivocerebellar projections are necessary for exogenous trophic factors to delay heredo-Purkinje cell degenerationBrian H. Hess, James A. Krewet, Daniel L. Tolbert · 2003 · Brain Research
- Spinocerebellar Ataxia Type 7: Clinical Features to Cellular PathogenesisGwenn A. Garden, Ray Truant, Lisa Ellerby, Albert R. La Spada · 2006 · Elsevier eBooks
- TRPC3 Antagonizes Pruritus in a Mouse Contact Dermatitis ModelKatherine Beattie, Haowu Jiang, Mayank Gautam, Mary K MacVittie, Barbara A. Miller, Minghong Ma, Qin Liu, Wenqin Luo · 2021 · Journal of Investigative Dermatology
- Polyglutamine Diseases and Neurodegeneration: The Example of Ataxin-1Cesira de Chiara, Annalisa Pastore · 2011 · Springer eBooks
- Qs in the NucleusHarry T. Orr · 2001 · Neuron
- Changes in mRNA content of developing opossum spinal cord at stages when regeneration can and cannot occur after injuryMiranda Mladinić, Marie E. Wintzer · 2002 · Brain Research Reviews
- Maladies par expansion de polyglutamine : données moléculaires et physiopathologiquesAnne-Sophie Lèbre, Alexis Brice · 2001 · médecine/sciences
- Triplet Repeat DiseasesStephan J. Guyenet, Albert R. La Spada · 2006 · Encyclopedia of Molecular Cell Biology and Molecular Medicine
- TRPC3 Channel Activity and Viability of Purkinje Neurons can be Regulated by a Local SignalosomeNaveed Aslam, Farah Alvi · 2022 · Frontiers in Molecular Biosciences
- The neglected role of endocannabinoid actions at TRPC channels in ataxiaHoda Ranjbar, Monavareh Soti, Moazamehosadat Razavinasab, Kristi A. Kohlmeier, Mohammad Shabani · 2022 · Neuroscience & Biobehavioral Reviews
- The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in diseaseManish Kumar, Nishu Tyagi, Mohammed Faruq · 2023 · Emerging Topics in Life Sciences
- Pathological Bergmann glia alterations and disrupted calcium dynamics in ataxic Canavan disease miceVanessa L. Hull, Yan Wang, Travis Burns, Sarah Sternbach, Shuaishuai Gong, Jennifer Ann McDonough, Fuzheng Guo, Laura N. Borodinsky, David Pleasure · 2023 · Glia
- Ataxin active site determination using spectral distribution of electron ion interaction potentials of amino acidsElena Pirogova, Vuk Vojisavljević, José Luís Hernández Cáceres, Irena Ćosić · 2010 · Medical & Biological Engineering & Computing
- Transactivation Domain of Human c-Myc Is Essential to Alleviate Poly(Q)-Mediated Neurotoxicity in Drosophila Disease ModelsKritika Raj, Surajit Sarkar · 2017 · Journal of Molecular Neuroscience
- Degradation properties of polyglutamine-expanded human androgen receptor in transfected cellsDaniel A. Cullen, P. Nigel Leigh, Jean‐Marc Gallo · 2004 · Neuroscience Letters
- Alterations in molecular chaperones and eIF2α during lung endothelial cell apoptosisQing Lü, Matthew D. Jankowich, Julie Newton, Elizabeth O. Harrington, Sharon Rounds · 2010 · American Journal of Physiology-Lung Cellular and Molecular Physiology
- Phenotypical, genotypical and pathological characterization of the moonwalker mouse, a model of ataxiaGabriella Sekerková, Sumeyra Kilic, Yen-Hsin Cheng, Natalie Fredrick, Anne Osmani, Haram R. Kim, Puneet Opal, Marco Martina · 2024 · Neurobiology of Disease
- The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?Hiroshi Mitoma, Kazuhiko Yamaguchi, Jérôme Honnorat, Mario Ubaldo Manto · 2022 · Brain Sciences
- Recent Advancements in Targeted Delivery of Therapeutic Molecules in Neurodegenerative Disease–-Spinocerebellar Ataxia–-Opportunities and ChallengesSatya Prakash, Meenakshi Malhotra · 2008 · Drug Target Insights
- A survey of trinucleotide/tandem repeat-containing transcripts (TNRTs) isolated from human spinal cord to identify genes containing unstable DNA regions as candidates for disorders of motor functionAndrea Malaspina, Narendra Kumar Kaushik, Jacqueline de Belleroche · 2001 · Brain Research Bulletin
- Pathological Mechanisms in Polyglutamine Expansion DiseasesDidier Devys, Gaël Yvert, Astrid Lunkes, Yvon Trottier, Jean‐Louis Mandel · 2001 · Advances in experimental medicine and biology
- Dominantly Inherited Spinocerebellar SyndromesStephen M. Maricich, Huda Yahya Zoghbi · 2014 · Elsevier eBooks
- Chapter 4 Clinical and Genetic Aspects of Spinocerebellar Ataxias with Emphasis on Polyglutamine ExpansionsGiovanni Stévanin, Alexandra Dürr, Alexis Brice · 2007 · Blue books of neurology
- Spectrins in Human DiseasesMarie‐Christine Lecomte · 2012 · Humana Press eBooks
- Neurodegeneration in the polyglutamine diseases: Act 1, Scene 1Robert Luke Nussbaum, Georg W. J. Auburger · 2000 · Nature Neuroscience
- IP3 Receptors in Neurodegenerative Disorders: Spinocerebellar Ataxias and Huntington’s and Alzheimer’s DiseasesMasayoshi Tada, Masatoyo Nishizawa, Osamu Onodera · 2013 · Springer eBooks